Clinical Diagnostics Products & Reviews

Clinical diagnostics encompasses the detection, diagnosis, and monitoring of diseases and health conditions in patients. Utilizing advanced lab techniques and medical technologies, clinical scientists and healthcare professionals analyze samples such as blood, urine, and tissue to identify biomarkers, pathogens, and other indicators of illness. From point of care testing (POCT) to precision medicine approaches, clinical diagnostics plays a crucial role in early intervention, treatment planning, and disease management. Explore how this field empowers clinicians to deliver accurate diagnoses and improve patient outcomes.

Product Filter

Clinical Diagnostics
Browse by Techniques
LumiraDx

Ratings

Search

LumiraDx Platform

LumiraDx

Next-generation point of care diagnostic platform - Next-generation microfluidic technology on the LumiraDx Platform enables lab-comparable performance across a broad menu of diagnostic assays.

0.0/5.0
|0 Reviews

CRP Test

LumiraDx

The LumiraDx CRP Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify CRP levels in whole blood and plasma. Used with the LumiraDx Platform, the Test delivers rapid, quantitative results in 4 minutes at the point of care.

0.0/5.0
|0 Reviews

D-Dimer Test

LumiraDx

The LumiraDx D-Dimer Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify D-Dimer levels in whole blood and plasma. It is the only direct fingerstick D-Dimer assay available today*, aiding healthcare professionals to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) in symptomatic patients with confidence** - in only 6 minutes.

0.0/5.0
|0 Reviews

HbA1C Test

LumiraDx

The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in approximately < 7 minutes at the point of care.

0.0/5.0
|0 Reviews

INR Test

LumiraDx

The LumiraDx INR Test measures prothrombin time reported as International Normalized Ratio (INR) from a single, direct fingerstick blood sample – all in less than 90 seconds*. The Test is used for monitoring patients on oral anticoagulation therapy with Vitamin-K Antagonist (VKA) drugs. Used with the LumiraDx Instrument, the Test delivers rapid results at the point of care.

0.0/5.0
|0 Reviews

NT-proBNP Test

LumiraDx

The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP in human capillary and venous whole blood and plasma samples (Lithium Heparin). Used with the LumiraDx Platform, the LumiraDx NT-proBNP test delivers rapid, reliable results in 12 minutes at the point of care.

0.0/5.0
|0 Reviews

SARS-CoV-2 Ab Test

LumiraDx

The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.

0.0/5.0
|0 Reviews

SARS-CoV-2 Ag Test

LumiraDx

The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal and nasopharyngeal swab specimens from individuals suspected of COVID-19 or asymptomatic individuals. Used with the LumiraDx Platform the test delivers rapid results at the point of care.

0.0/5.0
|0 Reviews

Sars-CoV-2 Ag Ultra Test

LumiraDx

Lab-comparable results in just 5 minutes - With excellent performance and results in just 5 minutes, the LumiraDx SARS-CoV-2 Ag Ultra test enables you to accurately and confidently test more patients, optimize clinic workflows and help triage patients without delay

0.0/5.0
|0 Reviews

SARS-CoV-2 Ag Pool Test

LumiraDx

The LumiraDx SARS-CoV-2 Ag Pool Test is a rapid microfluidic immunofluorescence assay for the qualitative detection of the nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens pooled from up to 5 individuals suspected of COVID-19 or up to 5 asymptomatic individuals. Used with the LumiraDx Platform the test offers a rapid, scalable and cost-effective screening solution for infectious individuals.

0.0/5.0
|0 Reviews